Mar 12, 2024 / 12:30PM GMT
Operator
Good morning, ladies and gentlemen, and welcome to the CorMedix Inc., fourth-quarter and full-year 2023 earnings call. (Operator Instructions) This call is being recorded on March 12, 2024.
I would now like to turn the conference over to Dan Ferry from LifeSci Advisors. Please go ahead.
Dan Ferry - LifeSci Advisors - IR
Good morning and welcome to the CorMedix full-year 2023 earnings conference call. Leading the call today is Joe Todisco, Chief Executive Officer of CorMedix. He is joined by Dr. Matt David, Executive Vice President and CFO; Beth Zelnick Kaufman, EVP and Chief Legal Officer; Liz Hurlburt, EVP of Chief Clinical Strategy and Operations Officer; and Erin Mistry, EVP and Chief Commercial Officer.
Before we begin, I would like to remind everyone that during the call, management may make what are known as forward-looking statements within the meaning set forth in the Private Securities Litigation Reform Act of 1995.
These statements are subject to certain risks and uncertainties and include but are not limited to any of the
Q4 2023 CorMedix Inc Earnings Call Transcript
Mar 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers